**Question:** Scl-70 antibody is characteristics of

A. Systemic sclerosis
B. Systemic lupus erythematosus
C. Sjogren's syndrome
D. Rheumatoid arthritis

**Core Concept:**
The Scl-70 antibody, also known as anti-topoisomerase I antibody, is a specific autoantibody found in patients with an autoimmune disease called systemic sclerosis (scleroderma). Systemic sclerosis is a rare connective tissue disease characterized by excessive fibrosis (scarring) and vascular abnormalities in the skin, internal organs, and blood vessels.

**Why the Correct Answer is Right:**
Scl-70 antibody is specific to systemic sclerosis because it is produced by the immune system against the topoisomerase I enzyme, which is involved in DNA replication and repair. In systemic sclerosis, the immune system mistakenly targets and damages the normal cells and tissues, leading to the production of Scl-70 antibodies.

**Why Each Wrong Option is Incorrect:**
A. Systemic sclerosis is associated with Scl-70 antibodies, not systemic lupus erythematosus, which is also an autoimmune disease but with different autoantibodies like anti-dsDNA and anti-Sm.

B. Systemic sclerosis is not a characteristic of systemic lupus erythematosus, which is an autoimmune disease involving various organs and is associated with different autoantibodies, including anti-Sm and anti-dsDNA.

C. Sjogren's syndrome is a separate autoimmune disease characterized by dry eyes, dry mouth, and lymphocytic infiltration of the exocrine glands, distinct from systemic sclerosis and associated with different autoantibodies like anti-Ro and anti-La.

D. Rheumatoid arthritis is a different autoimmune disease primarily affecting joints, with different autoantibodies such as rheumatoid factor and anti-citrullinated peptide antibodies, unlike Scl-70 antibodies found in systemic sclerosis.

**Clinical Pearl:**
Understanding the presence of Scl-70 antibodies in a patient can help in the correct diagnosis of systemic sclerosis, as the absence of these antibodies usually rules out the disease. This knowledge is crucial for early recognition and appropriate management of this potentially life-threatening condition.